Driving reinvestment in R&D for antibiotics and advocating their responsible use
About Drive AB
Partners
Work packages
Events
DRIVE-AB
Developing new economic models to incentivise antibiotic discovery and development activities while safeguarding the efficacy of antibiotics by researching and advocating their appropriate use.
News
-
A New Ecosystem Approach to Fight Antibiotic ResistanceDRIVE-AB issues final report on its research-based suggestions for driving antibiotic development while ensuring access and sustainable use. For...
-
DRIVE-AB final conference_Overview and materialsThe final DRIVE-AB conference, “Revitalizing the antibiotic pipeline: Stimulating innovation while driving sustainable use and global access”, was...
-
Revitalizing the Antibiotic Pipeline: DRIVE-AB Conference Speakers AnnouncedThe speakers and panelists for the upcoming DRIVE-AB conference, Revitalizing the Antibiotic Pipeline, have now been
-
-
Economic Incentives for Antimicrobial Drugs Proposed by Duke-Margolis CentreThe Duke-Margolis Centre for Health Policy in the United States has released a paper describing U.S. policy approaches that...